miR‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver

Liver resection is still the most commonly used therapeutic treatment for hepatocellular carcinoma (HCC), and liver regeneration promotes HCC growth in the regenerating liver. The high recurrence/metastasis of HCC is the main cause of death for HCC patients after liver resection. However, how the au...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Sci
Egile Nagusiak: Zheng, Xiao‐Bo, Chen, Xiao‐Bo, Xu, Liang‐Liang, Zhang, Ming, Feng, Lei, Yi, Peng‐Sheng, Tang, Jian‐Wei, Xu, Ming‐Qing
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378262/
https://ncbi.nlm.nih.gov/pubmed/28100026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13167
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak